WallStreetZenWallStreetZen

NASDAQ: CLYM
Climb Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CLYM stock forecasts and price targets.

Forecast return on equity

Is CLYM forecast to generate an efficient return?

Company
-55.09%
Industry
118.54%
Market
79.49%
CLYM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLYM forecast to generate an efficient return on assets?

Company
-53.75%
Industry
38.01%
CLYM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLYM earnings per share forecast

What is CLYM's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.62
Avg 2 year Forecast
-$0.79
Avg 3 year Forecast
-$1.10

CLYM revenue forecast

What is CLYM's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$42.0M
Avg 2 year Forecast
$316.8M

CLYM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLYM$1.19N/AN/A
STRO$0.96$4.80+401.04%Hold
GUTS$1.65$10.00+506.06%Strong Buy
CBUS$2.35$21.50+814.89%Strong Buy
INZY$1.24$17.83+1,338.15%Strong Buy
View Top Biotech Stocks

Climb Bio Stock Forecast FAQ

What is CLYM's earnings growth forecast for 2025-2027?

(NASDAQ: CLYM) Climb Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.

Climb Bio's earnings in 2025 is -$73,897,000.On average, 1 Wall Street analyst forecast CLYM's earnings for 2025 to be -$41,834,745, with the lowest CLYM earnings forecast at -$41,834,745, and the highest CLYM earnings forecast at -$41,834,745. On average, 1 Wall Street analyst forecast CLYM's earnings for 2026 to be -$53,305,562, with the lowest CLYM earnings forecast at -$53,305,562, and the highest CLYM earnings forecast at -$53,305,562.

In 2027, CLYM is forecast to generate -$74,222,935 in earnings, with the lowest earnings forecast at -$74,222,935 and the highest earnings forecast at -$74,222,935.

If you're new to stock investing, here's how to buy Climb Bio stock.

What is CLYM's revenue growth forecast for 2030-2031?

(NASDAQ: CLYM) Climb Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.

Climb Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast CLYM's revenue for 2030 to be $2,833,966,590, with the lowest CLYM revenue forecast at $2,833,966,590, and the highest CLYM revenue forecast at $2,833,966,590.

In 2031, CLYM is forecast to generate $21,376,205,136 in revenue, with the lowest revenue forecast at $21,376,205,136 and the highest revenue forecast at $21,376,205,136.

What is CLYM's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CLYM) forecast ROA is -53.75%, which is lower than the forecast US Biotechnology industry average of 38.01%.

What is CLYM's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CLYM) Climb Bio's current Earnings Per Share (EPS) is -$1.53. On average, analysts forecast that CLYM's EPS will be -$0.62 for 2025, with the lowest EPS forecast at -$0.62, and the highest EPS forecast at -$0.62. On average, analysts forecast that CLYM's EPS will be -$0.79 for 2026, with the lowest EPS forecast at -$0.79, and the highest EPS forecast at -$0.79. In 2027, CLYM's EPS is forecast to hit -$1.10 (min: -$1.10, max: -$1.10).

What is CLYM's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CLYM) forecast ROE is -55.09%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.